Life Science

61% of UK adults surveyed believe scientific breakthroughs happen as a result of one or two geniuses.

They will explore the role of autophagy in the progression of the disease.

The Milton lab is offering a personalised test from pMorph.

Struggling to finish your entry on time? Get in touch.

Professor Sir Shankar Balasubramanian led the research.

The Cambridge team led research exploring how the virus harvests a product of our cells.

It will give the company access to a pipeline of kidney and heart drugs.

10,000 patients will be offered personalised treatment by 2030, it pledges.

Entry closes this month - so don’t delay.

Key early-stage Cambridge bioscience hub appoints first director, science and entrepreneurship

It will aid pre-clinical development of therapies focused on neurodegenerative diseases.

It is working with the Medicines Discovery Catapult.

The co-founder and CEO has changed how small molecule drugs are discovered around the world.

The Granta Park company has entered a collaboration on diabetes and metabolic diseases.

The protein products specialist expects its headcount to more than treble in three years.

The biopharmaceutical company says it is assessing the damage at the Discovery Centre.

Cancer drugs Lynparza, Imfinzi and Enhertu feature.

The owners wanted to create something that represented the area.

They want to open up new druggable spaces.

It combines information on the genetic make-up and prostate cancer family history.